Oops! Looks like you don't currently have access.
Your current membership doesn’t include access to this page, but don’t worry we can fix that.
To obtain access to this data,
contact Klas
at
Radiation Therapy
Subject Expert
Recent Insights
Radiation Therapy 2017: Technology Outpacing Interoperability
Since KLAS last reported on radiation therapy in 2014, the overall high-performing market has seen some significant changes—adoption of Elekta’s go-forward platform (the Versa HD) has increased, and Varian customers have seen positive shifts in support...
Featured Report
Preferences
Konfidence
KLAS Konfidence refers to the number of unique organizations contributing evaluations to the overall score (minimum of 15 required).
Radiation Therapy
# of Unique Organization Evaluations:
| 0 - 5 | |
| 6 - 14 | L |
| 15 - 19 | |
| 20 - 29 | |
| 30 or more |
Exceptions
| R | Regional Classification |
| C | Component Products |
| S | Superseded Products |
| NP | Not Primary Products |